功能限制预测了心力衰竭的死亡率,其中保留了喷射分数
Domenico Scrutinio1, Pietro Guida2, Andrea Passantino1
1Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Bari, Via Generale Nicola Bellomo 73/75, Bari, Italy.
European journal of internal medicine
|July 31, 2024
概括
六分钟步行测试 (6MWT) 距离有效地预测了心力衰竭的死亡率,其中保留喷射分数 (HFpEF) 患者. 在6MWT期间步行较短的距离表明HFpEF中3年全因死亡率的风险明显更高.
科学领域:
- 心脏病学 心脏病学
- 临床医学 临床医学
- 预测 预测 预测 预测 预测
背景情况:
- 六分钟步行测试 (6MWT) 的预后值被确定为心力衰竭与减少喷射率 (HFrEF).
- 有限的数据存在于6MWD和心力衰竭与保存喷射分数 (HFpEF) 的死亡率之间的相关性.
研究的目的:
- 调查6MWT (6MWD) 期间行走的距离与HFpEF患者3年全因死亡率之间的关联.
- 为了确定6MWD是否在HFpEF中提供预后信息.
主要方法:
- 研究了一组482名HFpEF患者的队列,这些患者被录入住院心脏康复中心.
- 主要结局是3年全因死亡率.
- 使用结合已确定的风险标志物的多变量模型来评估6MWD与死亡率之间的关联.
主要成果:
- 在3年的随访期间,174名患者死亡.
- 在6MWD (≤240 m) 最低三分之一的患者,与最高三分之一 (≥360 m) 相比,死亡率的调整危险比率 (HR) (4.94) 显著更高.
- 当对年龄,性别和BMI进行正常化时,预测步行距离百分比的最低三位数 (≤58.1%) 显示出较高的调整HR (3.52) 死亡率.
结论:
- 在6MWT期间行走的距离为HFpEF患者提供了重要的预后信息.
- 通过6MWT评估功能能力对于HFpEF中的风险分层是有价值的.
- 通过6MWD测量较低的功能能力与HFpEF的死亡风险增加有关.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Heart Failure Drugs: β-Blockers
332
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332
Pathophysiology of Cardiac Performance
624
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
624


